Previous close | 3.6800 |
Open | 3.7100 |
Bid | 0.0000 x 1400 |
Ask | 0.0000 x 3100 |
Day's range | 3.5700 - 3.7660 |
52-week range | 0.4300 - 5.5800 |
Volume | |
Avg. volume | 272,861 |
Market cap | 104.885M |
Beta (5Y monthly) | 1.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 15, 2024, Harry Kovelman, Chief Medical Officer of Myomo Inc (MYO), executed a sale of 35,426 shares of the company.
Aligns with EPS Projections, Misses Revenue Estimates
Despite a widened net loss, Myomo Inc reports a significant increase in revenue and backlog, setting a positive trajectory for future performance.